Immune microenvironment dysfunctions enable malignification at the onset of myelodysplastic syndromes

Authors

Irene Ganan-Gomez, The University of Texas MD Anderson Cancer Center
Feiyang Ma, The University of Texas MD Anderson Cancer Center
Kelly S. Chien, The University of Texas MD Anderson Cancer Center
Hui Yang, The University of Texas MD Anderson Cancer Center
Guillermo Montalban-Bravo, The University of Texas MD Anderson Cancer Center
Bethany E. Wildeman, The University of Texas MD Anderson Cancer Center
Bijender Kumar, The University of Texas MD Anderson Cancer Center
Yi June Kim, The University of Texas MD Anderson Cancer Center
May Daher, The University of Texas MD Anderson Cancer Center
Koichi Takahashi MD, PhD, The University of Texas MD Anderson Cancer Center
Guillermo Garcia-Manero MD, The University of Texas MD Anderson Cancer Center
Simona Colla, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00055

Publication Date

11-2022

Department

Leukemia

Research Category

Clonal Expansion in Normal and Pathological Tissues

Recommended Citation

Ganan-Gomez, Irene; Ma, Feiyang; Chien, Kelly S.; Yang, Hui; Montalban-Bravo, Guillermo; Wildeman, Bethany E.; Kumar, Bijender; Kim, Yi June; Daher, May; Takahashi, Koichi MD, PhD; Garcia-Manero, Guillermo MD; and Colla, Simona, "Immune microenvironment dysfunctions enable malignification at the onset of myelodysplastic syndromes" (2022). Leading Edge of Cancer Research Symposium. 3.
doi:https://doi.org/10.52519/00055